News | December 07, 2025
Paradigm Health to acquire Flatiron’s clinical research business
It's an acquisition that aims at forming one of the US's largest oncology trial networks
It's an acquisition that aims at forming one of the US's largest oncology trial networks
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The center will offer training to super-specialist doctors and healthcare professionals in various fields
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Subscribe To Our Newsletter & Stay Updated
